Abstract
Therapy to reduce the occurrence and symptoms of angina have been less well investigated than drugs to prevent myocardial infarction and death. This article summarizes the current options for anti-anginal and anti-ischaemic drugs and explains why new therapeutic options are needed.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: European heart journal supplements : journal of the European Society of Cardiology
Paper Title
Journal
Date
